A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : iPSCs / induced pluripotent stem cells

[Related PubMed/MEDLINE]
Total Number of Papers: 4062
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   iPSCs  (>> Co-occurring Abbreviation)
Long Form:   induced pluripotent stem cells
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
1  2021 Differentiation of Human Induced Pluripotent Stem Cells into Epicardial-Like Cells. iECs
2  2021 Generation of Human Induced Pluripotent Stem Cells and Differentiation into Cardiomyocytes. ---
3  2021 Production and Analysis of Human Primordial Germ Cell-Like Cells. EBs, PGCs
4  2020 A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes. hiPSC-CMs
5  2020 A Guide to Understanding "State-of-the-Art" Basic Research Techniques in Anesthesiology. CRISPR, NGS
6  2020 A Highly Phenotyped Open Access Repository of Alpha-1 Antitrypsin Deficiency Pluripotent Stem Cells. AATD
7  2020 A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15. CNVs
8  2020 A lithium-containing biomaterial promotes chondrogenic differentiation of induced pluripotent stem cells with reducing hypertrophy. MMP13, SOX9, TCP
9  2020 A method for establishing the electrophysiological model of alcoholic cardiomyopathy. CCK-8, LDH, RTCA
10  2020 A method of generating alveolar organoids using human pluripotent stem cells. AOs, AT2
11  2020 A potential ex vivo infection model of human induced pluripotent stem cell-3D organoids beyond coronavirus disease 2019. COVID-19
12  2020 A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer's Disease and Frontotemporal Dementia Disease Modeling. BFCNs
13  2020 A Single "All-in-One" Helper-Dependent Adenovirus to Deliver Donor DNA and CRISPR/Cas9 for Efficient Homology-Directed Repair. Cas9, gRNA, HDAd
14  2020 AAV-mediated FOXG1 gene editing in human Rett primary cells. AAVs, FOXG1, NGS, sgRNAs
15  2020 Aberrant Development Corrected in Adult-Onset Huntington's Disease iPSC-Derived Neuronal Cultures via WNT Signaling Modulation. HD, NSC
16  2020 Acceleration of somatic cell reprogramming into the induced pluripotent stem cell using a mycosporine-like amino acid, Porphyra 334. HDP, MAA, MET, TTFs
17  2020 Accept or Reject: The Role of Immune Tolerance in the Development of Stem Cell Therapies and Possible Future Approaches. ESCs
18  2020 Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term programming. HSCs, HSPCs, PSCs
19  2020 Acute Myeloid Leukemia iPSCs Reveal a Role for RUNX1 in the Maintenance of Human Leukemia Stem Cells. AML, LSCs
20  2020 Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes. ---
21  2020 Adhering to Ethical Benchmarks in Neurology Clinical Trials Using iPSCs. ---
22  2020 Advances in Human Induced Pluripotent Stem Cell-Derived Hepatocytes for Use in Toxicity Testing. HLCs
23  2020 Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications. PSCs
24  2020 Advantages and Recent Developments of Autologous Cell Therapy for Parkinson's Disease Patients. DA, mDA, NHPs, PD
25  2020 An Insight into Reprogramming Barriers to iPSC Generation. ---
26  2020 An integration-free iPSC line SDQLCHi025-A from a girl with multiminicore disease carrying compound heterozygote mutations in RYR1 gene. ---
27  2020 Analysis of genes involved in cell proliferation, adhesion, and control of apoptosis during embryonic neurogenesis in Induced Pluripotent Stem Cells (iPSCs) from patients with Focal Cortical Dysplasia. FCD
28  2020 Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia. ---
29  2020 Anatomical templates for tissue (re)generation and beyond. ---
30  2020 Apolipoprotein E4 and meningeal lymphatics in Alzheimer disease: a conceptual framework. AD
31  2020 Application of induced pluripotent stem cells in epilepsy. AEDs
32  2020 Applications for Induced Pluripotent Stem Cells in Disease Modelling and Drug Development for Heart Diseases. ---
33  2020 ARHGAP10, which encodes Rho GTPase-activating protein 10, is a novel gene for schizophrenia risk. CNV, mPFC, SCZ, TH
34  2020 Assembly and Function of a Bioengineered Human Liver for Transplantation Generated Solely from Induced Pluripotent Stem Cells. ---
35  2020 Autologous cell replacement: a noninvasive AI approach to clinical release testing. RPE
36  2020 Automated in-process characterization and selection of cell-clones for quality and efficient cell manufacturing. MSCs
37  2020 Base Editor Correction of COL7A1 in RecessiveDystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and iPSCs. ABE, HDR, RDEB
38  2020 Beneficial effects of cysteamine in Thy1-alpha-Syn mice and induced pluripotent stem cells with a SNCA gene triplication. PD
39  2020 Biallelic correction of sickle cell disease-derived induced pluripotent stem cells (iPSCs) confirmed at the protein level through serum-free iPS-sac/erythroid differentiation. hESC, SCD
40  2020 Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients. AGS, AT
41  2020 Biomaterials and Culture Systems for Development of Organoid and Organ-on-a-Chip Models. ASCs
42  2020 Biomimetic nanovesicles made from iPS cell-derived mesenchymal stem cells for targeted therapy of triple-negative breast cancer. MSCs, TNBC
43  2020 Cancer stem cell generation by silenced MAPK enhancing PI3K/AKT signaling. ---
44  2020 Cardiac repair in a murine model of myocardial infarction with human induced pluripotent stem cell-derived cardiomyocytes. HF, iPS-CMs, LV, LVEF, LVIDd, MI
45  2020 Cell therapy for spinal cord injury by using human iPSC-derived region-specific neural progenitor cells. NPCs, SCI
46  2020 Cellular Functions of OCT-3/4 Regulated by Ubiquitination in Proliferating Cells. ESCs, KLF4, SOX2, UPS
47  2020 Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells. ESCs, MSCs
48  2020 Characterization of Endoplasmic Reticulum (ER) in Human Pluripotent Stem Cells Revealed Increased Susceptibility to Cell Death upon ER Stress. BiP, ER, ESCs, hPSCs
49  2020 Characterization of human iPSC-derived astrocytes with potential for disease modeling and drug discovery. ---
50  2020 Characterization of Human iPSC-derived Spinal Motor Neurons by Single-cell RNA Sequencing. MN
51  2020 Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion. ---
52  2020 Characterization of Induced Pluripotent Stem Cells from Human Epidermal Melanocytes by Transduction with Two Combinations of Transcription Factors. ---
53  2020 Characterizing and inferring quantitative cell cycle phase in single-cell RNA-seq data analysis. scRNA-seq
54  2020 Chimeric G-CSF Receptor-Mediated STAT3 Activation Contributes to Efficient Induction of Cardiomyocytes from Mouse Induced Pluripotent Stem Cells. FL, G-CSF, JAK, STAT
55  2020 Cohen Syndrome Patient iPSC-Derived Neurospheres and Forebrain-Like Glutamatergic Neurons Reveal Reduced Proliferation of Neural Progenitor Cells and Altered Expression of Synapse Genes. CS
56  2020 Comparative transcriptomic analysis of cerebral organoids and cortical neuron cultures derived from human induced pluripotent stem cells. PFC
57  2020 Comparison of human-induced pluripotent stem cells and mesenchymal stem cell differentiation potential to insulin producing cells in 2D and 3D culture systems in vitro. IPCs, MSCs, PEG, PLGA, TCPS
58  2020 Complete neural stem cell (NSC) neuronal differentiation requires a branched chain amino acids-induced persistent metabolic shift towards energy metabolism. NSC, ROS
59  2020 Conducting Polymer Mediated Electrical Stimulation Induces Multilineage Differentiation with Robust Neuronal Fate Determination of Human Induced Pluripotent Stem Cells. CPs, DBS, PPy
60  2020 Congenital pituitary hypoplasia model demonstrates hypothalamic OTX2 regulation of pituitary progenitor cells. CPH, OTX2
61  2020 Construction of a doxycycline inducible lentivirus that expresses stem cell-specific miR-302 cluster. ---
62  2020 Construction of induced pluripotent stem cell line (ZZUi0017-A) from the fibroblast cells of a female patient with CACNA1A mutation by unintegrated reprogramming approach. ---
63  2020 Copy number variants (CNVs): a powerful tool for iPSC-based modelling of ASD. ASD, CNVs, NDD
64  2020 Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing. DMD, sgRNAs
65  2020 CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation. EB
66  2020 CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs. Cas, CRISPR, HB, HLCs
67  2020 CRISPR/Cas9-Mediated Gene Correction to Understand ALS. ALS
68  2020 CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced Pluripotent Stem Cells. ---
69  2020 Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients. ADPKD
70  2020 Cytokine Directed Chondroblast Trans-Differentiation: JAK Inhibition Facilitates Direct Reprogramming of Fibroblasts to Chondroblasts. OA
71  2020 Deciphering the Proteome Dynamics during Development of Neurons Derived from Induced Pluripotent Stem Cells. ---
72  2020 Defining Transcription Regulatory Elements in the Human Frataxin Gene: Implications for Gene Therapy. FRDA, FXN
73  2020 Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease. alpha-Syn, CPNs, Dupl, mDANs, PD
74  2020 DEPDC5 haploinsufficiency drives increased mTORC1 signaling and abnormal morphology in human iPSC-derived cortical neurons. ---
75  2020 Derivation and 97% Purification of Human Thyroid Cells From Dermal Fibroblasts. ES
76  2020 Derivation of induced pluripotent stem cells from ferret somatic cells. ---
77  2020 Derivation of two iPSC lines from a sporadic ASD patient (NUIGi033-A) and a paternal control (NUIGi034-A). ---
78  2020 Development of a 3-D Organoid System Using Human Induced Pluripotent Stem Cells to Model Idiopathic Autism. ASC
79  2020 Development of two-photon polymerised scaffolds for optical interrogation and neurite guidance of human iPSC-derived cortical neuronal networks. ---
80  2020 Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids. scRNA-seq
81  2020 Different gene expression profiles in iPSC-derived motor neurons from ALS8 patients with variable clinical courses suggest mitigating pathways for neurodegeneration. ALS8, CNV, ER, WES
82  2020 Differentiation and characterization of neurons derived from rat iPSCs. riPSC
83  2020 Differentiation and expansion of endothelial cells requires pre-optimization of KDR+ expression kinetics. ECs, hPSCs
84  2020 Differentiation of human airway-organoids from induced pluripotent stem cells (iPSCs). iPSC
85  2020 Differentiation of Intrafusal Fibers from Human Induced Pluripotent Stem Cells. ---
86  2020 Diminished expression of major histocompatibility complex facilitates the use of human induced pluripotent stem cells in monkey. B2M
87  2020 Direct Comparison of Four Hematopoietic Differentiation Methods from Human Induced Pluripotent Stem Cells. ---
88  2020 DNA methylation changes in Down syndrome derived neural iPSCs uncover co-dysregulation of ZNF and HOX3 families of transcription factors. DS
89  2020 Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs). hESCs
90  2020 Double sperm cloning (DSC) is a promising strategy in mammalian genetic engineering and stem cell research. DSC, ESCs, ICSI, SCNT
91  2020 Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach. IFD, NS and LS
92  2020 Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders. ASD, BPD, hESCs, ID, NDDs, SCZ
93  2020 Effective restoration of dystrophin expression in iPSC Mdx-derived muscle progenitor cells using the CRISPR/Cas9 system and homology-directed repair technology. DeltaEx23, DMD, Dox, HDR, MPC
94  2020 Effects of intermittent treatment with parathyroid hormone (PTH) on osteoblastic differentiation and mineralization of mouse induced pluripotent stem cells in a 3D culture model. ACS, ALP, CLSM, COL1A1, EB, miPSCs, OBM, PTH, PTH1R
95  2020 Efficient Generation and Transcriptomic Profiling of Human iPSC-Derived Pulmonary Neuroendocrine Cells. iPNECs, PNECs, scRNA-seq
96  2020 Efficient generation of thymic epithelium from induced pluripotent stem cells that prolongs allograft survival. iPSC-TECs, TECs
97  2020 Efficient RNA-Based Reprogramming of Disease-Associated Primary Human Fibroblasts into Induced Pluripotent Stem Cells. ---
98  2020 Elimination of Teratogenic Human Induced Pluripotent Stem Cells by Bee Venom via Calcium-Calpain Pathway. BV, iPSCs-Diff
99  2020 Embryonal Carcinoma and Glioblastoma Cell Lines Derived from Monkey Induced Pluripotent Stem Cells. ---
100  2020 Endoplasmic Reticulum Stress Activation in Alport Syndrome Varies Between Genotype and Cell Type. ERS, XLAS